ARCHIVES

JCO Retracts Key Duke Genomics Paper; Duke Shuts Down Three Phase II Trials

This article is from The Cancer Letter archive.

Vol. 36 No. 42 | November 19, 2010

Download PDF Visit The Full Archive

Related Articles

Appropriators Project 1.2% Increase for NIH, Due to Budget Plan

June 20, 1997

NCI RFA: Basic Biobehavioral Research

August 6, 1999

DCT Advisors Reject MRS Concept, Approve RDOG Expansion

November 30, 1990

Recombinant TSH Avoids Need To Stop Replacement Therapy

January 27, 2006

President Calls For Reversing Cuts to Basic Research Budget

January 31, 2014

Implantable Drug Delivery Device Offers Better Pain Relief

September 27, 2002